HIF2α-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma
Open accessPublished version of a preprint
Abstract
Two hallmarks of clear-cell renal cell carcinoma (ccRCC) are constitutive hypoxia-inducible factor (HIF) signaling and abundant intracellular lipid droplets (LD). However, regulation of lipid storage and its role in ccRCC are incompletely understood. Transcriptional profiling of primary ccRCC samples revealed that expression of the LD coat protein gene PLIN2 was elevated in tumors and correlated with HIF2α, but not HIF1α, activation. HIF2α-dependent PLIN2 expression promoted lipid storage, proliferation, and viability in xenograft tumors. Mechanistically, lipid storage maintained integrity of the endoplasmic reticulum (ER), which is functionally and physically associated with LDs. Specifically, PLIN2-dependent lipid storage suppressed cytotoxic ER stress responses that otherwise result from elevated protein synthetic activity characteristic of ccRCC cells. Thus, in addition to promoting ccRCC proliferation and anabolic metabolism, HIF2α modulates lipid storage to sustain ER homeostasis, particularly under conditions of nutrient and oxygen limitation, thereby promoting tumor cell survival. Significance: We demonstrate that HIF2α promotes lipid storage, ER homeostasis, and cell viability in ccRCC via upregulation of the LD coat protein PLIN2, revealing a novel function for the well-documented “clear-cell” phenotype and identifying ER stress as a targetable vulnerability created by HIF2α/PLIN2 suppression in this common renal malignancy. Cancer Discov; 5(6); 652–67. ©2015 AACR. See related commentary by Sim and Johnson, p. 584. This article is highlighted in the In This Issue feature, p. 565
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Fatty acid synthesis induced by HIF-2α is crucial for cell viability in ccRCC by sustaining endoplasmic reticulum homeostasis.
“Fatty acid synthesis induced by HIF-2α is crucial for cell viability in ccRCC by sustaining endoplasmic reticulum (ER) homeostasis77.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [77]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
Walter, P., & Ron, D. (2011) · Science · doi:10.1126/science.1209038 · Cited by 5,893 · see citing works
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,834 · see citing works
Comprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485 · see citing works
Triglyceride accumulation protects against fatty acid-induced lipotoxicity
Listenberger, L. L., Han, X., Lewis, S. E., Cases, S., Farese, R. V., Ory, D. S., & Schaffer, J. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630588100 · Cited by 2,075 · see citing works
Activation of a metabolic gene regulatory network downstream of mTOR complex 1
Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020 · see citing works
SUnSET, a nonradioactive method to monitor protein synthesis
Schmidt, E. K., Clavarino, G., Ceppi, M., & Pierre, P. (2009) · Nature Methods · doi:10.1038/nmeth.1314 · Cited by 1,706 · see citing works
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693 · see citing works
Self-citationMacropinocytosis of protein is an amino acid supply route in Ras-transformed cells
Commisso, C., Davidson, S. M., Soydaner-Azeloglu, R. G., Parker, S. J., Kamphorst, J. J., Hackett, S., Grabocka, E., Nofal, M., Drebin, J. A., Thompson, C. B., et al. (2013) · Nature · doi:10.1038/nature12138 · Cited by 1,683 · see citing works
Lipid Droplets and Cellular Lipid Metabolism
Walther, T. C., & Farese, R. V. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061009-102430 · Cited by 1,668 · see citing works
Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation
Hu, C.-J., Wang, L.-Y., Chodosh, L. A., Keith, B., & Simon, M. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9361-9374.2003 · Cited by 1,386 · see citing works
Self-citationmTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway
Peterson, T. R., Sengupta, S., Harris, T. E., Carmack, A. E., Kang, S. A. W., Balderas, E., Guertin, D. A., Madden, K. L., Carpenter, A. E., Finck, B. N., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.034 · Cited by 1,233 · see citing works
Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells
Obeng, E. A., Carlson, L. M., Gutman, D. M., Harrington, W. J., Lee, K. P., & Boise, L. (2006) · Blood · doi:10.1182/blood-2005-08-3531 · Cited by 1,147 · see citing works
Fu, S., Yang, L., Li, P., Hofmann, O., Dicker, L. H., Hide, W. A., Lin, X., Watkins, S. M., Ivanov, A. R., & Hotamışlıgil, G. S. (2011) · Nature · doi:10.1038/nature09968 · Cited by 1,024 · see citing works
Yue, S., Li, J., Lee, S. Y., Lee, H. J., Shao, T., Song, B., Liang Cheng, C., Masterson, T. A., Liu, X., Ratliff, T. L., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.019 · Cited by 931 · see citing works
Measuring ER Stress and the Unfolded Protein Response Using Mammalian Tissue Culture System
Oslowski, C. M., & Urano, F. (2011) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-385114-7.00004-0 · Cited by 925 · see citing works
Wilfling, F., Wang, H., Haas, J. T., Krahmer, N., Gould, T. J., Uchida, A., Cheng, J.-X., Graham, M., Christiano, R., Fröhlich, F., et al. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.01.013 · Cited by 806 · see citing works
Kammoun, H. L., Chabanon, H., Hainault, I., Luquet, S., Magnan, C., Koike, T., Ferré, P., & Foufelle, F. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37007 · Cited by 732 · see citing works
Kamphorst, J. J., Cross, J. R., Fan, J., de Stanchina, E., Mathew, R., White, E. P., Thompson, C. B., & Rabinowitz, J. D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307237110 · Cited by 726 · see citing works
Bensaad, K., Favaro, E., Lewis, C. A., Peck, B., Lord, S., Collins, J. M., Pinnick, K. E., Wigfield, S., Buffa, F. M., Li, J., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.056 · Cited by 667 · see citing works
Volmer, R., van der Ploeg, K., & Ron, D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217611110 · Cited by 655 · see citing works
The role of lipid droplets in metabolic disease in rodents and humans
Greenberg, A. S., Coleman, R., Kraemer, F. B., McManaman, J. L., Obin, M. S., Puri, V., Yan, Q.-W., Miyoshi, H., & Mashek, D. G. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46069 · Cited by 620 · see citing works
Cross, B. C. S., Bond, P. J., Sadowski, P. G., Jha, B. K., Žák, J., Goodman, J. M., Silverman, R. H., Neubert, T. A., Baxendale, I. R., Ron, D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115623109 · Cited by 593 · see citing works
Fructose-1,6-bisphosphatase opposes renal carcinoma progression
Li, B., Qiu, B., Lee, D. S. M., Walton, Z. E., Ochocki, J. D., Mathew, L. K., Mancuso, A., Gade, T. P. F., Keith, B., Nissim, I., et al. (2014) · Nature · doi:10.1038/nature13557 · Cited by 535 · see citing works
Self-citationHypoxia, lipids, and cancer: surviving the harsh tumor microenvironment
Ackerman, D., & Simon, M. C. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.06.001 · Cited by 495 · see citing works
Self-citationHIF-α effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma
Gordan, J. D., Lal, P., Dondeti, V. R., Letrero, R., Parekh, K. N., Oquendo, C. E., Greenberg, R. A., Flaherty, K. T., Rathmell, W. K., Keith, B., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.016 · Cited by 493 · see citing works
Self-citationGene Signatures of Progression and Metastasis in Renal Cell Cancer
Jones, J., Otu, H. H., Spentzos, D., Kolia, S., Inan, M. S., Beecken, W. D., Fellbaum, C., Gu, X., Joseph, M. G., Pantuck, A. J., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2225 · Cited by 450 · see citing works
Lipid droplets in inflammation and cancer
Bozza, P. T., & Viola, J. P. B. (2010) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1016/j.plefa.2010.02.005 · Cited by 446 · see citing works
Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity
Atkins, C., Liu, Q., Minthorn, E., Zhang, S.-Y., Figueroa, D. J., Moss, K., Stanley, T. B., Sanders, B., Goetz, A., Gaul, N., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3109 · Cited by 443 · see citing works
ER stress–mediated autophagy promotes Myc-dependent transformation and tumor growth
Hart, L. S., Cunningham, J. T., Datta, T., Dey, S., Tameire, F., Lehman, S. L., Qiu, B., Zhang, H., Cerniglia, G. J., Bi, M., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62973 · Cited by 436 · see citing works
Self-citationGenetic and Functional Studies Implicate <i>HIF1</i> α as a 14q Kidney Cancer Suppressor Gene
Shen, C., Beroukhim, R., Schumacher, S. E., Zhou, J., Chang, M., Signoretti, S., & Kaelin, W. G. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0098 · Cited by 413 · see citing works
The VHL/HIF axis in clear cell renal carcinoma
Shen, C., & Kaelin, W. G. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.06.001 · Cited by 387 · see citing works
Hypoxia-inducible factor 2 regulates hepatic lipid metabolism
Rankin, E. B., Rha, J., Selak, M. A., Unger, T. L., Keith, B., Liu, Q., & Haase, V. H. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00200-09 · Cited by 338 · see citing works
Self-citationHepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration
Sun, Z., Miller, R. A., Patel, R. T., Chen, J., Dhir, R., Wang, H., Zhang, D., Graham, M. J., Unterman, T. G., Shulman, G. I., et al. (2012) · Nature Medicine · doi:10.1038/nm.2744 · Cited by 335 · see citing works
Chang, B. H., Li, L., Paul, A., Taniguchi, S., Nannegari, V., Heird, W. C., & Chan, L. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.3.1063-1076.2006 · Cited by 309 · see citing works
ADRP stimulates lipid accumulation and lipid droplet formation in murine fibroblasts
Imamura, M., Inoguchi, T., Ikuyama, S., Taniguchi, S., Kobayashi, K., Nakashima, N., & Nawata, H. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00040.2002 · Cited by 281 · see citing works
Purdue, M. P., Johansson, M., Zélénika, D., Toro, J. R., Scélo, G., Moore, L. E., Prokhortchouk, E., Wu, X., Kiemeney, L. A. L. M., Gaborieau, V., et al. (2010) · Nature Genetics · doi:10.1038/ng.723 · Cited by 236 · see citing works
Failure to prolyl hydroxylate hypoxia‐inducible factor α phenocopies VHL inactivation in vivo
Kim, W. Y., Safran, M., Buckley, M. R., Ebert, B. L., Glickman, J., Bosenberg, M., Regan, M., & Kaelin, W. G. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601300 · Cited by 235 · see citing works
Young, R. M., Ackerman, D., Quinn, Z. L., Mancuso, A., Gruber, M., Liu, L., Giannoukos, D. N., Bobrovnikova-Marjon, E. V., Diehl, J. A., Keith, B., et al. (2013) · Genes & Development · doi:10.1101/gad.198630.112 · Cited by 214 · see citing works
Self-citationHIF2α Acts as an mTORC1 Activator through the Amino Acid Carrier SLC7A5
Elorza, A., Soro-Arnáiz, I., Meléndez‐Rodríguez, F., Rodríguez-Vaello, V., Marsboom, G., de Cárcer, G., Acosta‐Iborra, B., Albacete-Albacete, L., Ordóñez, Á., Serrano‐Oviedo, L., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.017 · Cited by 206 · see citing works
Phase II Trial of Bortezomib for Patients With Advanced Renal Cell Carcinoma
Kondagunta, G. V., Drucker, B. J., Schwartz, L. I., Bacik, J., Marion, S., Russo, P., Mazumdar, M., & Motzer, R. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.155 · Cited by 193 · see citing works
Hif-2α Promotes Degradation of Mammalian Peroxisomes by Selective Autophagy
Walter, K., Schönenberger, M. J., Trötzmüller, M., Horn, M., Elsässer, H., Moser, A. B., Lucas, M. S., Schwarz, T., Gerber, P. A., Faust, P. L., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.09.017 · Cited by 164 · see citing works
Schödel, J., Bardella, C., Sciesielski, L. K., Brown, J. M., Pugh, C. W., Buckle, V. J., Tomlinson, I. P. M., Ratcliffe, P. J., & Mole, D. R. (2012) · Nature Genetics · doi:10.1038/ng.2204 · Cited by 157 · see citing works
Fels, D. R., Ye, J., Segan, A. T., Kridel, S. J., Spiotto, M. T., Olson, M., Koong, A. C., & Koumenis, C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2873 · Cited by 132 · see citing works
Ling, S. C. W., Lau, E. K. K., Al-Shabeeb, A., Nikolic, A., Catalano, A., Iland, H., Horvath, N., Ho, P. J., Harrison, S., Fleming, S., et al. (2012) · Haematologica · doi:10.3324/haematol.2011.043331 · Cited by 130 · see citing works
Sztalryd, C., Bell, M., Lu, X., Mertz, P. S., Hickenbottom, S. J., Chang, B. H., Chan, L., Kimmel, A. R., & Londos, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602497200 · Cited by 122 · see citing works
Inoue, K., Kawahito, Y., Tsubouchi, Y., Kohno, M., Yoshimura, R., Yoshikawa, T., & Sano, H. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5640 · Cited by 86 · see citing works
Kawabata, S., Gills, J. J., Mercado-Matos, J., LoPiccolo, J., Wilson, W. H., Hollander, M. C., & Dennis, P. A. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.87 · Cited by 69 · see citing works
Imai, Y., Boyle, S., Varela, G. M., Caron, É., Yin, X., Dhir, R., Dhir, R. N., Graham, M. J., & Ahima, R. S. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00045.2012 · Cited by 66 · see citing works
Röschinger, W., Muntau, A. C., Durán, M., DORLAND, L., IJlst, L., Wanders, R. J. A., & Roscher, A. A. (2000) · Clinica Chimica Acta · doi:10.1016/s0009-8981(00)00268-0 · Cited by 52 · see citing works
Perilipin 2 (PLIN2)-Deficiency Does Not Increase Cholesterol-Induced Toxicity in Macrophages
Son, S., Goo, Y., Chang, B. H., & Paul, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033063 · Cited by 30 · see citing works
Haddad, A., Kapur, P., Singla, N., Raman, J. D., Then, M. T., Nuhn, P., Büchner, A., Bastian, P. J., Seitz, C., Shariat, S. F., et al. (2014) · Cancer · doi:10.1002/cncr.28976 · Cited by 22 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Understanding the Intersections between Metabolism and Cancer Biology
Heiden, M. G. V., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,316 · see citing works
Lipid metabolic reprogramming in cancer cells
Beloribi‐Djefaflia, S., Vasseur, S., & Guillaumond, F. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.49 · Cited by 1,392 · see citing works
Cellular Adaptation to Hypoxia through Hypoxia Inducible Factors and beyond
Lee, P., Chandel, N. S., & Simon, M. C. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0227-y · Cited by 1,272 · see citing works
Self-citationGlutamine reliance in cell metabolism
Yoo, H. C., Yu, Y. C., Sung, Y., & Han, J. M. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00504-8 · Cited by 1,021 · see citing works
Zou, Y., Palte, M. J., Deik, A. A., Li, H., Eaton, J. K., Wang, W., Tseng, Y.-Y., Deasy, R., Kost-Alimova, M., Dančík, V., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09277-9 · Cited by 887 · see citing works
Lipid droplet biogenesis and functions in health and disease
Zadoorian, A., Du, X., & Yang, H. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00845-0 · Cited by 617 · see citing works
Lipid droplet functions beyond energy storage
Welte, M. A., & Gould, A. P. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.07.006 · Cited by 574 · see citing works
Lipid droplets: platforms with multiple functions in cancer hallmarks
Cruz, A. L. S., Barreto, E. A., Fazolini, N. P. B., Viola, J. P. B., & Bozza, P. T. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2297-3 · Cited by 539 · see citing works
Lipid metabolism in sickness and in health: Emerging regulators of lipotoxicity
Yoon, H., Shaw, J. L., Haigis, M. C., & Greka, A. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.027 · Cited by 521 · see citing works
Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target
Infantino, V., Santarsiero, A., Convertini, P., Todisco, S., & Iacobazzi, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115703 · Cited by 510 · see citing works
Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics
Jin, H.-R., Wang, J., Wang, Z., Xi, M., Xia, B., Deng, K., & Yang, J. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01498-2 · Cited by 509 · see citing works
HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism
Du, W., Zhang, L., Brett-Morris, A., Aguila, B., Kerner, J., Hoppel, C. L., Puchowicz, M., Serra, D., Herrero, L., Rini, B. I., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01965-8 · Cited by 468 · see citing works
Oxygen availability and metabolic adaptations
Nakazawa, M. S., Keith, B., & Simon, M. C. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.84 · Cited by 430 · see citing works
Self-citationLipid metabolism in cancer progression and therapeutic strategies
Fu, Y., Zou, T., Shen, X., Nelson, P. J., Li, J., Wu, C., Yang, J., Zheng, Y., Bruns, C. J., Zhao, Y., et al. (2020) · MedComm · doi:10.1002/mco2.27 · Cited by 406 · see citing works
Targeting lipid metabolism of cancer cells: A promising therapeutic strategy for cancer
Liu, Q., Luo, Q., Halim, A., & Song, G. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.05.002 · Cited by 381 · see citing works
A new perspective on NAFLD: Focusing on lipid droplets
Scorletti, E., & Carr, R. M. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.11.009 · Cited by 376 · see citing works
Lipid Droplets in Cancer: Guardians of Fat in a Stressful World
Petan, T., Jovičić, E. J., & Jusović, M. (2018) · Molecules · doi:10.3390/molecules23081941 · Cited by 369 · see citing works
Adipocyte-Derived Lipids Mediate Melanoma Progression via FATP Proteins
Zhang, M., Martino, J. S. D., Bowman, R. L., Campbell, N. R., Baksh, S. C., Simon-Vermot, T., Kim, I. S., Haldeman, P. B., Mondal, C., Yong-Gonzales, V., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1371 · Cited by 368 · see citing works
Cotte, A. K., Aires, V., Fredon, M., Limagne, E., Dérangère, V., Thibaudin, M., Humblin, É., Scagliarini, A., de Barros, J.-P. P., Hillon, P., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02732-5 · Cited by 365 · see citing works
Miess, H., Dankworth, B., Gouw, A. M., Rosenfeldt, M., Schmitz, W., Jiang, M., Saunders, B., Howell, M., Downward, J., Felsher, D. W., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0315-z · Cited by 361 · see citing works
Targeting DGAT1 Ameliorates Glioblastoma by Increasing Fat Catabolism and Oxidative Stress
Cheng, X., Geng, F., Pan, M., Wu, X., Zhong, Y., Wang, C., Tian, Z., Cheng, C., Zhang, R., Puduvalli, V. K., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.002 · Cited by 348 · see citing works
Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways
Jia, D., Lu, M., Jung, K. H., Park, J. H., Yu, L., Onuchic, J. N., Kaipparettu, B. A., & Levine, H. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1816391116 · Cited by 338 · see citing works
Hypoxia-inducible factors and the regulation of lipid metabolism
Mylonis, I., Simos, G., & Paraskeva, E. (2019) · Cells · doi:10.3390/cells8030214 · Cited by 316 · see citing works
Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy
Riera-Domingo, C., Audigé, A., Granja, S., Cheng, W.-C., Ho, P.-C., Baltazar, F., Stockmann, C., & Mazzone, M. (2020) · Physiological Reviews · doi:10.1152/physrev.00018.2019 · Cited by 310 · see citing works
Triglycerides Promote Lipid Homeostasis during Hypoxic Stress by Balancing Fatty Acid Saturation
Ackerman, D., Tumanov, S., Qiu, B., Michalopoulou, E., Spata, M., Azzam, A., Xie, H. J., Simon, M. C., & Kamphorst, J. J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.015 · Cited by 307 · see citing works
Self-citationEndoplasmic reticulum stress and lipids in health and diseases
Celik, C., Lee, S. Y. T., Yap, W. S., & Thibault, G. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101198 · Cited by 275 · see citing works
PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function
Morotti, M., Grimm, A. J., Hope, H. C., Arnaud, M., Desbuisson, M., Rayroux, N., Barras, D., Masid, M., Murgues, B., Chap, B. S., et al. (2024) · Nature · doi:10.1038/s41586-024-07352-w · Cited by 230 · see citing works
Cancer Cells Don’t Live Alone: Metabolic Communication within Tumor Microenvironments
Li, F., & Simon, M. C. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.06.018 · Cited by 226 · see citing works
Self-citationKurihara, T., Westenskow, P. D., Gantner, M. L., Usui, Y., Schultz, A. W., Bravo, S., Aguilar, E., Wittgrove, C. M., Friedlander, M. S. H., Paris, L. P., et al. (2016) · eLife · doi:10.7554/elife.14319 · Cited by 214 · see citing works
Even Cancer Cells Watch Their Cholesterol!
Riscal, R., Skuli, N., & Simon, M. C. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.09.008 · Cited by 214 · see citing works
Self-citationKoizume, S., & Miyagi, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091430 · Cited by 209 · see citing works
Metabolic reprogramming in renal cancer: Events of a metabolic disease
Chakraborty, S., Balan, M., Sabarwal, A., Choueiri, T. K., & Pal, S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188559 · Cited by 208 · see citing works
Oxygen availability and metabolic reprogramming in cancer
Xie, H. J., & Simon, M. C. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.799973 · Cited by 203 · see citing works
Self-citationVHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma
Zhang, J., Wu, T., Simon, J. M., Takada, M., Saito, R., Fan, C., Liu, X.-D., Jonasch, E. W., Xie, L., Chen, X., et al. (2018) · Science · doi:10.1126/science.aap8411 · Cited by 204 · see citing works
Association of tamoxifen resistance and lipid reprogramming in breast cancer
Hultsch, S., Kankainen, M., Paavolainen, L., Kovanen, R., Ikonen, E., Kangaspeska, S., Pietiäinen, V. M., & Kallioniemi, O. (2018) · BMC Cancer · doi:10.1186/s12885-018-4757-z · Cited by 195 · see citing works
Hu, J., Wang, S., Hou, Y., Chen, Z., Liu, L., Li, R., Li, N., Zhou, L., Yang, Y., Wang, L., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01662-5 · Cited by 194 · see citing works
Disorders of cancer metabolism: The therapeutic potential of cannabinoids
Sun, D., Li, X., Nie, S., Liu, J., & Wang, S. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113993 · Cited by 187 · see citing works
Hu, J., Chen, Z., Bao, L., Zhou, L., Hou, Y., Liu, L., Xiong, M., Zhang, Y., Wang, B., Tao, Z., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.04.023 · Cited by 180 · see citing works
Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets
Tan, S. K., Hougen, H. Y., Merchan, J. R., Gonzalgo, M. L., & Welford, S. M. (2022) · Nature Reviews Urology · doi:10.1038/s41585-022-00654-6 · Cited by 178 · see citing works
di Meo, N. A., Lasorsa, F. M., Rutigliano, M., Loizzo, D., Ferro, M., Stella, A., Bizzoca, C., Vincenti, L., Pandolfo, S. D., Riccardo Autorino, B., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214360 · Cited by 181 · see citing works
Non-coding RNAs: the new central dogma of cancer biology
Saw, P. E., Xu, X., Chen, J., & Song, E. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1700-9 · Cited by 176 · see citing works
VHL Deficiency Drives Enhancer Activation of Oncogenes in Clear Cell Renal Cell Carcinoma
Yao, X., Tan, J. Y., Lim, K. J., Koh, J., Ooi, W. F., Li, Z., Huang, D., Xing, M., Chan, Y. S., Qu, J. Z., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0375 · Cited by 166 · see citing works
Genetic and metabolic hallmarks of clear cell renal cell carcinoma
Sanchez, D. J., & Simon, M. C. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.06.003 · Cited by 161 · see citing works
Self-citationThe Distinct Role of HIF-1α and HIF-2α in Hypoxia and Angiogenesis
Bakleh, M. Z., & Zen, A. A. H. (2025) · Cells · doi:10.3390/cells14090673 · Cited by 171 · see citing works
GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment
Missiaen, R., Anderson, N. M., Kim, L. C., Nance, B., Burrows, M., Skuli, N., Carens, M., Riscal, R., Steensels, A., Li, F., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.06.010 · Cited by 156 · see citing works
Self-citationLipid Metabolism and Lipid Droplets in Pancreatic Cancer and Stellate Cells
Sunami, Y., Rebelo, A., & Kleeff, J. H. (2017) · Cancers · doi:10.3390/cancers10010003 · Cited by 154 · see citing works
Inhibition of intracellular lipolysis promotes human cancer cell adaptation to hypoxia
Zhang, X., Saarinen, A. M., Hitosugi, T., Wang, Z., Wang, L., Ho, T. H., & Liu, J. (2017) · eLife · doi:10.7554/elife.31132 · Cited by 150 · see citing works
A Label-Free Platform for Identification of Exosomes from Different Sources
Yan, Z., Dutta, S., Liu, Z., Yu, X., Mesgarzadeh, N., Ji, F., Bitan, G., & Xie, Y. (2019) · ACS Sensors · doi:10.1021/acssensors.8b01564 · Cited by 149 · see citing works
Immunogenic ferroptosis and where to find it?
Demuynck, R., Efimova, I., Naessens, F., & Krysko, D. V. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003430 · Cited by 147 · see citing works
Senga, S., Kobayashi, N., Kawaguchi, K., Ando, A., & Fujii, H. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.06.010 · Cited by 142 · see citing works
The tumour microenvironment and metabolism in renal cell carcinoma targeted or immune therapy
Lai, Y., Tang, F., Huang, Y., He, C., Chen, C., Zhao, J., Wu, W., & He, Z. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29969 · Cited by 139 · see citing works
Bombelli, S., Torsello, B., Marco, S. D., Lucarelli, G. T., Cifola, I., Grasselli, C., Strada, G., Bovo, G., Perego, R., & Bianchi, C. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.08.008 · Cited by 142 · see citing works
Klasson, T. D., LaGory, E. L., Zhao, H., Huynh, S. K., Papandreou, I., Moon, E. J., & Giaccia, A. J. (2022) · Cancer & Metabolism · doi:10.1186/s40170-022-00290-z · Cited by 138 · see citing works
Petan, T. (2020) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2020_51 · Cited by 139 · see citing works
IRE1α RNase–dependent lipid homeostasis promotes survival in Myc-transformed cancers
Xie, H. J., Tang, C.-H. A., Song, J. H., Mancuso, A., Valle, J. R. D., Cao, J., Xiang, Y., Dang, C. V., Lan, R., Sanchez, D. J., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95864 · Cited by 132 · see citing works
Self-citationAugustin, R. C., Delgoffe, G. M., & Najjar, Y. G. (2020) · Cancers · doi:10.3390/cancers12123802 · Cited by 130 · see citing works
Cholesterol Auxotrophy as a Targetable Vulnerability in Clear Cell Renal Cell Carcinoma
Riscal, R., Bull, C. J., Mesaros, C., Finan, J. M., Carens, M., Ho, E. S., Xu, J. P., Godfrey, J., Brennan, P., Johansson, M., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0211 · Cited by 120 · see citing works
Self-citationGiacomini, I., Gianfanti, F., Desbats, M. A., Orso, G., Berretta, M., Prayer‐Galetti, T., Ragazzi, E., & Cocetta, V. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.682911 · Cited by 120 · see citing works
Wei, G., Sun, H., Dong, K., Hu, L., Wang, Q., Zhuang, Q., Zhu, Y., Zhang, X., Shao, Y., Tang, H., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.08.012 · Cited by 120 · see citing works
Diet, lipids, and antitumor immunity
Prendeville, H., & Lynch, L. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00781-x · Cited by 122 · see citing works
MTHFD2 links RNA methylation to metabolic reprogramming in renal cell carcinoma
Green, N. H., Galvan, D. L., Badal, S. S., Chang, B. H., LeBleu, V. S., Long, J., Jonasch, E., & Danesh, F. R. (2019) · Oncogene · doi:10.1038/s41388-019-0869-4 · Cited by 117 · see citing works
Lipid Metabolism and Resistance to Anticancer Treatment
Germain, N., Dhayer, M., Boileau, M., Fovez, Q., Kluza, J., & Marchetti, P. (2020) · Biology · doi:10.3390/biology9120474 · Cited by 115 · see citing works
Hypoxia, angiogenesis, and metabolism in the hereditary kidney cancers
Chappell, J. C., Payne, L. B., & Rathmell, W. K. (2019) · Journal of Clinical Investigation · doi:10.1172/jci120855 · Cited by 114 · see citing works
The roles of sirtuins family in cell metabolism during tumor development
Zhu, S., Dong, Z., Ke, X., Hou, J., Zhao, E., Zhang, K., Wang, F., Yang, L., Xiang, Z., & Cui, H. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.11.003 · Cited by 113 · see citing works
The Role of Tumour Metabolism in Cisplatin Resistance
Wang, L., Zhao, X., Fu, J., Xu, W., & Yuan, J. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.691795 · Cited by 109 · see citing works
Lipid metabolism reprogramming in renal cell carcinoma
Heravi, G., Yazdanpanah, O., Podgorski, I., Matherly, L. H., & Liu, W. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09996-w · Cited by 105 · see citing works
Mazumder, S., Higgins, P. J., & Samarakoon, R. (2023) · Cancers · doi:10.3390/cancers15041316 · Cited by 109 · see citing works
Deep, G., & Schlaepfer, I. R. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071061 · Cited by 101 · see citing works
Tan, S. K., Mahmud, I., Fontanesi, F., Puchowicz, M., Neumann, C. K. A., Griswold, A. J., Patel, R., Dispagna, M., Ahmed, H. H., Gonzalgo, M. L., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1453 · Cited by 101 · see citing works
Lipid Metabolism in Oncology: Why It Matters, How to Research, and How to Treat
Matsushita, Y., Nakagawa, H., & Koike, K. (2021) · Cancers · doi:10.3390/cancers13030474 · Cited by 100 · see citing works
A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma
Syafruddin, S. E., Rodrigues, P., Vojtasova, E., Patel, S. A., Zaini, M. N., Burge, J., Warren, A. Y., Stewart, G. D., Eisen, T. G., Bihary, D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09116-x · Cited by 95 · see citing works
Hao, X., Ren, Y., Feng, M., Wang, Q., & Wang, Y. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111798 · Cited by 98 · see citing works
Neutral Lipid Storage Diseases as Cellular Model to Study Lipid Droplet Function
Missaglia, S., Coleman, R., Mordente, A., & Tavian, D. (2019) · Cells · doi:10.3390/cells8020187 · Cited by 93 · see citing works
Lucarelli, G. T., Ferro, M., Loizzo, D., Bianchi, C., Terracciano, D., Cantiello, F., Bell, L. N., Battaglia, S., Porta, C., Gernone, A., et al. (2020) · Metabolites · doi:10.3390/metabo10120509 · Cited by 93 · see citing works
Characterization of Lipid and Lipid Droplet Metabolism in Human HCC
Berndt, N., Eckstein, J., Heucke, N., Gajowski, R., Stockmann, M., Meierhofer, D., & Holzhütter, H. (2019) · Cells · doi:10.3390/cells8050512 · Cited by 92 · see citing works
Han, X., Zhu, J., Zhang, X., Song, Q., Ding, J., Lu, M., Sun, S., & Hu, G. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00397 · Cited by 91 · see citing works
Molecular Crosstalk Between MYC and HIF in Cancer
Li, Y., Sun, X., Qian, D. Z., & Dai, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.590576 · Cited by 90 · see citing works
Hints on ATGL implications in cancer: beyond bioenergetic clues
Vegliante, R., Leo, L. D., Ciccarone, F., & Ciriolo, M. R. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0345-z · Cited by 89 · see citing works
Sun, X., Yang, S., Feng, X., Zheng, Y., Zhou, J., Wang, H., Zhang, Y., Sun, H., & He, C. (2019) · Gastric Cancer · doi:10.1007/s10120-019-01004-z · Cited by 89 · see citing works
The size matters: regulation of lipid storage by lipid droplet dynamics
Yu, J., & Li, P. (2016) · Science China Life Sciences · doi:10.1007/s11427-016-0322-x · Cited by 87 · see citing works
Lipid droplets, potential biomarker and metabolic target in glioblastoma
Guo, D. (2017) · Internal Medicine Review · doi:10.18103/imr.v3i5.443 · Cited by 83 · see citing works
Shah, S., Carriveau, W. J., Li, J., Campbell, S. L., Kopinski, P. K., Lim, H., Daurio, N. A., Trefely, S., Won, K., Wallace, D. C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9666 · Cited by 83 · see citing works
Von Hippel–Lindau protein signalling in clear cell renal cell carcinoma
Liao, C., Hu, L., & Zhang, Q. H. (2024) · Nature Reviews Urology · doi:10.1038/s41585-024-00876-w · Cited by 83 · see citing works
Novel drugs that target the metabolic reprogramming in renal cell cancer
van der Mijn, J. C., Panka, D. J., Geissler, A. K., Verheul, H. M. W., & Mier, J. W. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0154-8 · Cited by 81 · see citing works
Omega-3 fatty acids, membrane remodeling and cancer prevention
Fuentes, N. R., Kim, E., Fan, Y., & Chapkin, R. S. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.04.001 · Cited by 80 · see citing works
Ortmann, B. M., Burrows, N., Lobb, I. T., Arnaiz, E., Wit, N., Bailey, P. S. J., Jordon, L., Lombardi, O., Peñalver, A., McCaffrey, J., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00887-y · Cited by 79 · see citing works
Zhou, J. R., Simon, J. M., Liao, C., Zhang, C., Hu, L., Zurlo, G., Liu, X., Fan, C., Hepperla, A. J., Jia, L., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.06.003 · Cited by 77 · see citing works
Cao, Q., Ruan, H., Wang, K., Song, Z., Bao, L., Xu, T., Xiao, H., Wang, C., Cheng, G., Tong, J., et al. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4384 · Cited by 76 · see citing works
VandeKopple, M. J., Wu, J., Auer, E. N., Giaccia, A. J., Denko, N. C., & Papandreou, I. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-1343 · Cited by 74 · see citing works
Links between cancer metabolism and cisplatin resistance
Cocetta, V., Ragazzi, E., & Montopoli, M. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2020.01.005 · Cited by 75 · see citing works
Tumor microenvironmental nutrients, cellular responses, and cancer
Lobel, G. P., Jiang, Y., & Simon, M. C. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.08.011 · Cited by 74 · see citing works
Self-citationMissiaen, R., Lesner, N. P., & Simon, M. C. (2023) · The EMBO Journal · doi:10.15252/embj.2022112067 · Cited by 74 · see citing works
Self-citationRecent advances in expanding the coverage of the lipidome
Tumanov, S., & Kamphorst, J. J. (2016) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2016.11.008 · Cited by 73 · see citing works
SREBP-1 upregulates lipophagy to maintain cholesterol homeostasis in brain tumor cells
Geng, F., Zhong, Y., Su, H., Lefai, É., Magaki, S., Cloughesy, T. F., Yong, W. H., Chakravarti, A., & Guo, D. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112790 · Cited by 72 · see citing works
Triantafyllou, E.-A., Georgatsou, E., Mylonis, I., Simos, G., & Paraskeva, E. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.06.015 · Cited by 71 · see citing works
New dawn for cancer cell death: Emerging role of lipid metabolism
Zhang, C., Zhu, N., Li, H., Gong, Y.-Z., Gu, J., Shi, Y., Liao, D., Wang, W., Dai, A., & Li, Q. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101529 · Cited by 65 · see citing works
Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunity
Ortmann, B. M. (2024) · BMJ Oncology · doi:10.1136/bmjonc-2023-000154 · Cited by 67 · see citing works
Interacting Cancer Machineries: Cell Signaling, Lipid Metabolism, and Epigenetics
Grunt, T. W. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.11.003 · Cited by 68 · see citing works
Zhou, L., Luo, Y., Liu, Y., Zeng, Y., Tong, J., Li, M., Hou, Y., Du, K., Qi, Y., Pan, W., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-0969 · Cited by 64 · see citing works
The pathogenesis and therapeutic implications of metabolic reprogramming in renal cell carcinoma
Zhang, Y., Zhang, S., Sun, H., & Xu, L. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02479-9 · Cited by 70 · see citing works
- Authors
- Qiu, B., Ackerman, D., Sanchez, D. J., Li, B., Ochocki, J. D., Grazioli, A., Bobrovnikova-Marjon, E., Diehl, J. A., Keith, B., & Simon, M. C.
- Affiliations
- University of Pennsylvania (US)
- Medical University of South Carolina (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Simon, M. Celeste
- ORCID
- Venue
- Cancer Discovery
- Published
- 2015-06-01
- Volume
- 5
- Issue
- 6
- Pages
- 652-667
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- PMC
- PMC4456212
- OpenAlex
- W2135546443
- Cited by
- 394
- References
- 51
- Citations by year
- 2026: 27 · 2025: 37 · 2024: 69 · 2023: 32 · 2022: 47 · 2021: 47 · 2020: 38 · 2019: 27 · 2018: 29 · 2017: 22 · 2016: 14 · 2015: 4
- FWCI
- 7.60
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Discovery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Cancer Institute (F30CA177106, 2-P01-CA104838, P01CA104838, 5-F30-CA177106, F32CA192758)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32HD083185)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- HIF-2α, clear cell renal cell carcinoma, lipid droplets, PLIN2, endoplasmic reticulum homeostasis, endoplasmic reticulum stress, fat deposition, tumor hypoxia, tumor cell survival
- MeSH terms
- Perilipin-2, Endothelial PAS Domain-Containing Protein 1, Animals, Carcinoma, Renal Cell, Cell Survival, Disease Models, Animal, Endoplasmic Reticulum, Homeostasis, Humans, Kidney Neoplasms, Membrane Proteins, Oncogenes, Protein Biosynthesis, Gene Expression, Gene Expression Regulation, Neoplastic, Drug Resistance, Neoplasm, Cell Line, Tumor, Tumor Burden, Lipid Metabolism, Mice, Basic Helix-Loop-Helix Proteins, Unfolded Protein Response, Endoplasmic Reticulum Stress, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review